Abstract

Lung squamous cell carcinoma (LUSC) is a subtype of non-small cell lung cancers which is the cause of 80% of all lung cancer deaths. The genes that highly mutated in patients with LUSC and their roles played in the tumorigenesis remains unknown. Data of patients with Lung squamous cell carcinoma (LUSC) were retrieved from The Cancer Genome Atlas (TCGA). Differentially expressed genes were identified between control and cancer samples. Patients and controls can be separated by mRNA expression level showing that the between-group variance and totally 1265 genes were differentially expressed between controls and patients. Top genes whose mutations highly occurred in patients with LUSC were identified, most of these genes were shown to be related with tumorigenesis in previous studies. All of the genes mostly mutated were independently correlated with expression levels of all genes. These mutations did not show the trend of co-occurrence. However, the influenced gene of these mutations had overlaps. After studying the intersection of these genes, a group of shared genes were identified. The shared pathways enriched which played critical role in LUSC were identified based on these shared genes. Different mutations had contribution to the progression of LUSC. Though these genes involved different specific mechanisms, most of them may share a common mechanism which is critical for LUSC. The results may suggest a neglected mechanism and also indicate a potential target for therapies.

Highlights

  • Lung cancer is the most common cause of deaths that related to cancer in the world

  • Patients and controls can be separated by mRNA expression level showing that the between-group variance and totally 1265 genes were differentially expressed between controls and patients

  • Top genes whose mutations highly occurred in patients with Lung squamous cell carcinoma (LUSC) were identified, most of these genes were shown to be related with tumorigenesis in previous studies

Read more

Summary

Introduction

Lung cancer is the most common cause of deaths that related to cancer in the world. While most cancers have a steady increase in survival in the past decades, lung cancers have slow advance in this aspect, whose currently 5-year relative survival is only 18% and 7%, respectively [3]. These low rates are, to some extent, associated with the fact that more than 50% of patients with LUSC are diagnosed at a distant stage [3]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call